Gene and Cell Therapies
Principles of Pharmaceutical Development
- 1st Edition - August 1, 2026
- Latest edition
- Author: Chris Van Der Walle
- Language: English
Interest in gene and cell therapies has increased dramatically following powerful demonstrations of their capability to treat rare genetic disorders, advanced cancers, and… Read more
Interest in gene and cell therapies has increased dramatically following powerful demonstrations of their capability to treat rare genetic disorders, advanced cancers, and regenerate or repair tissues. Although these new, advanced medicines are continually being improved upon, their complex manufacture remains a key obstacle to increasing patient access. Gene and Cell Therapies: Principles of Pharmaceutical Development provides insight to the key principles of emerging scientific and technical strategies to overcome these obstacles. How the design of viral vectors, oncolytic viruses, ribonucleic acid cancer vaccines, autologous and allogeneic cell therapies, impacts their pharmaceutical development is outlined. The advances in molecular and cell biology that have led to efficacious and safe gene and cell therapies are related to the process and analytical developments that ensure their quality. The scope and style, along with included case studies, learning points and lecture slides, will allow the non-specialist to develop a foundational understanding, while the contemporary concepts discussed will urge further advancement of these exciting medicines.
- Discusses the concepts behind marketed and future gene and cell therapies
- Details information from the molecular level to manufacturing strategies
- Includes timely and thought provoking material, for the student and professional in academia and industry
- Provides learning points, case studies and lecture slides to support the instructor teaching and student learning experiences
Undergraduate and postgraduate students studying for a degree in Pharmacy, Pharmaceutical Sciences, or Biomedical Sciences.
1. Introduction
2. Gene Therapies
3. Somatic Cell Therapies
4. Pharmaceutical Development
2. Gene Therapies
3. Somatic Cell Therapies
4. Pharmaceutical Development
- Edition: 1
- Latest edition
- Published: August 1, 2026
- Language: English
CV
Chris Van Der Walle
Dr Christopher van der Walle
Head of Formulation Sciences
Science, Research and Innovation group
The Medicines and Healthcare products Regulatory Agency
Blanche Lane, South Mimms, Potters Bar
Hertfordshire, EN6 3QG,
United Kingdom
E: [email protected]
W: nibsc.org
W: gov.uk/mhra
Affiliations and expertise
The Medicines and Healthcare products Regulatory Agency, UK